About 1 result found for searched term "Vanucizumab" (0.12 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24682 | Vanucizumab | VEGFR/PDGFR |
| Anti-Human VEGFA Recombinant Antibody RO5520985 | ||
| Vanucizumab is a first-in-class, bispecific IgG1-like monoclonal antibody that simultaneously blocks VEGF-A and angiopoietin-2 (Ang-2) from interacting with their receptors. Vanucizumab has antiangiogenic and anticancer effects. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
